XML 32 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
Share Based Compensation (Tables)
9 Months Ended
Sep. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Share-based Compensation

All stock-based compensation is included in operating expenses for the periods as follows:

 

    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2018     2017     2018     2017  
Compensation cost recognized:                                
Selling, general & administrative   $ 40,402     $ 84,538     $ 152,555     $ 261,696  
Research & development     3,057       6,274       15,605       20,634  
    $ 43,459     $ 90,812     $ 168,160     $ 282,330  

Schedule of Stock Option Activity

Stock option activity under the 2006 and 2015 Stock Option Plans (collectively, the “Plans”) during the periods indicated below were as follows:

 

    Number of Shares Subject to Issuance     Weighted-average Exercise Price     Weighted-average Remaining Contractual Term   Aggregate Intrinsic Value  
                       
Outstanding at December 31, 2017     1,631,358     $ 1.36     1.70 years   $ 2,106,669  
                             
Granted     102,500       2.86              
Forfeited or expired     (65,688 )     4.22              
Exercised     (593,838 )     1.16              
Outstanding at September 30, 2018     1,074,332       1.44     2.17 years   $ 1,227,767  
                             
Exercisable at September 30, 2018     939,332     $ 1.28     1.91 years   $ 1,197,417  

Schedule of Restricted Stock Units Outstanding

The compensation expense incurred by the Company for RSUs is based on the closing market price of the Company’s common stock on the date of grant and is amortized ratably on a straight-line basis over the requisite service period and charged to general and administrative expense with a corresponding increase to additional paid-in capital.

 

    Number of
Shares
    Weighted
Average
Grant Date
Fair Value
    Aggregate
Intrinsic
Value
 
                   
Outstanding at December 31, 2017     5,859     $ 2.56     $ -  
Granted     29,822       2.07          
Vested and settled in shares     (29,112 )     2.07          
                         
Outstanding at September 30, 2018     6,569     $ 2.51     $ -